The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero
Zosano Pharma Corp (ZSAN)

Zosano Pharma is a clinical stage pharmaceutical company that has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. ZP-Triptan, which is Co.'s formulation of zolmitriptan, one of a class of serotonin receptor agonists, used for the treatment of migraine; ZP-PTH, which is Co.'s formulation of teriparatide, a synthetic form of parathyroid hormone that regulates serum calcium, for the treatment of severe osteoporosis; and ZP-Glucagon, which is Co.'s formulation of glucagon, a hormone that raises blood glucose levels, for the treatment of patients suffering from severe hypoglycemia.

Company Name:  Zosano Pharma Corp
Website:  www.zosanopharma.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding ZSAN:  1
Total Market Value Held by ETFs:  $4472
Total Market Capitalization:  $29.00M
% of Market Cap. Held by ETFs:  0.02%
April 24, 2017    3:17 AM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes



Buy (3.33 out of 4)
60th percentile
(ranked higher than approx. 60% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Zosano Pharma Corp (ZSAN) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2017, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.